Recent advances in systemic therapy for breast cancer: new technologies for a new era

por Ellis, Paul
Publicado 2009

The essential guide to effect sizes: statistical power, meta-analysis, and the interpretation of research results

por Ellis, Paul D
Publicado 2010

Trends in Theoretical Physics Colloquia Series

por Ellis, Paul J, Tang, Y C
Publicado 1989

Trends in theoretical physics

por Tang, Y C, Ellis, Paul J
Publicado 1990

Colloquium Series of the Theoretical Physics Institute at the Univ. of Minnesota

por Ellis, Paul J, Tang, Y C
Publicado 1991

Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives

por Quinn, Mark, Ellis, Paul, Pye, Anita, Turner, Alice M
Publicado 2020

Dynamical Evolution of the Scalar Condensate in Heavy Ion Collisions

por Csernai, Laszlo P., Ellis, Paul J., Jeon, Sangyong, Kapusta, Joseph I.
Publicado 1999

New insights from broadband simulations into small overmoded smooth and corrugated terahertz waveguides and transitions for NMR-DNP

por Doty, F David, Doty, Glenn N., Staab, John P., Sizyuk, Yuriy, Ellis, Paul D.
Publicado 2021

Long-Term Mortality following Acute Noninvasive Ventilation for Obesity-Related Respiratory Failure: A Retrospective Single-Centre Study

por Krishnan, Aditya, Ellis, Paul, Antoine-Pitterson, Pearlene, Oakes, Amy, Jones, Bethany, Turner, Alice, Mukherjee, Rahul
Publicado 2023

Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial a...

por Kilburn, Lucy Suzanne, Aresu, Maria, Banerji, Jane, Barrett-Lee, Peter, Ellis, Paul, Bliss, Judith Margaret
Publicado 2017

Machine Learning in Colorectal Cancer Risk Prediction from Routinely Collected Data: A Review

por Burnett, Bruce, Zhou, Shang-Ming, Brophy, Sinead, Davies, Phil, Ellis, Paul, Kennedy, Jonathan, Bandyopadhyay, Amrita, Parker, Michael, Lyons, Ronan A.
Publicado 2023

Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models

por Stolzenburg, Lindsay R., Ainsworth, Barrett, Riley-Gillis, Bridget, Pakozdi, Tibor, Ammar, Areej, Ellis, Paul A., Wilsbacher, Julie L., Ramathal, Cyril Y.
Publicado 2022

The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients

por Kelleher, Muireann T., Fruhwirth, Gilbert, Patel, Gargi, Ofo, Enyinnaya, Festy, Frederic, Barber, Paul R., Ameer-Beg, Simon M., Vojnovic, Borivoj, Gillett, Cheryl, Coolen, Anthony, Kéri, György, Ellis, Paul A., Ng, Tony
Publicado 2009

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2–Positive, Advanced Breast Cancer: Primary Results From...

por Perez, Edith A., Barrios, Carlos, Eiermann, Wolfgang, Toi, Masakazu, Im, Young-Hyuck, Conte, Pierfranco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier, Burris, Howard A., Petersen, Jennifer A., Stanzel, Sven, Strasak, Alexander, Patre, Monika, Ellis, Paul
Publicado 2017

Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced bre...

por Perez, Edith A., de Haas, Sanne Lysbet, Eiermann, Wolfgang, Barrios, Carlos H., Toi, Masakazu, Im, Young-Hyuck, Conte, Pier Franco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier B., Burris, Howard A., Stanzel, Sven, Patre, Monika, Ellis, Paul Anthony
Publicado 2019

Correction to: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positi...

por Perez, Edith A., de Haas, Sanne Lysbet, Eiermann, Wolfgang, Barrios, Carlos H., Toi, Masakazu, Im, Young-Hyuck, Conte, Pier Franco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier B., Burris, Howard A., Stanzel, Sven, Patre, Monika, Ellis, Paul Anthony
Publicado 2019

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status

por Weitsman, Gregory, Barber, Paul R., Nguyen, Lan K., Lawler, Katherine, Patel, Gargi, Woodman, Natalie, Kelleher, Muireann T., Pinder, Sarah E., Rowley, Mark, Ellis, Paul A., Purushotham, Anand D., Coolen, Anthonius C., Kholodenko, Boris N., Vojnovic, Borivoj, Gillett, Cheryl, Ng, Tony
Publicado 2016

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

por Loi, Sherene, Haibe-Kains, Benjamin, Desmedt, Christine, Wirapati, Pratyaksha, Lallemand, Françoise, Tutt, Andrew M, Gillet, Cheryl, Ellis, Paul, Ryder, Kenneth, Reid, James F, Daidone, Maria G, Pierotti, Marco A, Berns, Els MJJ, Jansen, Maurice PHM, Foekens, John A, Delorenzi, Mauro, Bontempi, Gianluca, Piccart, Martine J, Sotiriou, Christos
Publicado 2008

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

por Ellis, Paul, Barrett-Lee, Peter, Johnson, Lindsay, Cameron, David, Wardley, Andrew, O'Reilly, Susan, Verrill, Mark, Smith, Ian, Yarnold, John, Coleman, Robert, Earl, Helena, Canney, Peter, Twelves, Chris, Poole, Christopher, Bloomfield, David, Hopwood, Penelope, Johnston, Stephen, Dowsett, Mitchell, Bartlett, John MS, Ellis, Ian, Peckitt, Clare, Hall, Emma, Bliss, Judith M
Publicado 2009

New paradigm for macromolecular crystallography experiments at SSRL: automated crystal screening and remote data collection

por Soltis, S. Michael, Cohen, Aina E., Deacon, Ashley, Eriksson, Thomas, González, Ana, McPhillips, Scott, Chui, Hsui, Dunten, Pete, Hollenbeck, Michael, Mathews, Irimpan, Miller, Mitch, Moorhead, Penjit, Phizackerley, R. Paul, Smith, Clyde, Song, Jinhu, van dem Bedem, Henry, Ellis, Paul, Kuhn, Peter, McPhillips, Timothy, Sauter, Nicholas, Sharp, Kenneth, Tsyba, Irina, Wolf, Guenter
Publicado 2008